Biological healing accelerator – Japan (License No. 5331482)
Patent Details
Country of RegistrationJapan
Patent No.No. 5331482Registration DateAugust 02, 2013Remarks※ Reduction of side effects of anti-cancer drugs
Currently, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been approved in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand to reduce the side effects of anticancer drugs and to promote healing of erythema caused by burn wounds.
This Japanese biological healing accelerator patent (License No.) covers Aureobasidium pullulans-derived β-glucan for accelerating biological healing processes, reflecting AP-glucan's potential tissue repair applications.
AP β-glucan demonstrated biological healing acceleration properties, likely through its immunostimulatory effects on macrophage function and anti-inflammatory activity. Enhanced macrophage activity in wound sites could accelerate tissue repair through improved debris clearance and growth factor production.
Tissue healing applications extend AP-glucan's therapeutic profile into wound healing and regenerative medicine contexts. The immune-tissue repair connection positions AP β-glucan as a potential multi-modal therapeutic supporting both immune defense and tissue recovery.
Iwai A., Uchiyama H.. Biological healing accelerator – Japan (License No. 5331482). Japanese Patent Office. 2023.
For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.